These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 23099330)
21. Microglia-derived HIV Nef+ exosome impairment of the blood-brain barrier is treatable by nanomedicine-based delivery of Nef peptides. Raymond AD; Diaz P; Chevelon S; Agudelo M; Yndart-Arias A; Ding H; Kaushik A; Jayant RD; Nikkhah-Moshaie R; Roy U; Pilakka-Kanthikeel S; Nair MP J Neurovirol; 2016 Apr; 22(2):129-39. PubMed ID: 26631079 [TBL] [Abstract][Full Text] [Related]
22. Induction of HIV-specific T and B cell responses with a replicating and conditionally infectious lentiviral vaccine. Wingard JB; Anderson B; Weissman D Eur J Immunol; 2008 May; 38(5):1310-20. PubMed ID: 18412164 [TBL] [Abstract][Full Text] [Related]
26. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies. Vietheer PT; Boo I; Drummer HE; Netter HJ Antivir Ther; 2007; 12(4):477-87. PubMed ID: 17668556 [TBL] [Abstract][Full Text] [Related]
27. Exploiting the yeast L-A viral capsid for the in vivo assembly of chimeric VLPs as platform in vaccine development and foreign protein expression. Powilleit F; Breinig T; Schmitt MJ PLoS One; 2007 May; 2(5):e415. PubMed ID: 17476337 [TBL] [Abstract][Full Text] [Related]
28. Assembly and extracellular release of chimeric HIV-1 Pr55gag retrovirus-like particles. Wagner R; Deml L; Fliessbach H; Wanner G; Wolf H Virology; 1994 Apr; 200(1):162-75. PubMed ID: 7510434 [TBL] [Abstract][Full Text] [Related]
29. Virus-like particles: designing an effective AIDS vaccine. Young KR; McBurney SP; Karkhanis LU; Ross TM Methods; 2006 Sep; 40(1):98-117. PubMed ID: 16997718 [TBL] [Abstract][Full Text] [Related]
30. CD8+ T cell cross-priming via transfer of proteasome substrates. Norbury CC; Basta S; Donohue KB; Tscharke DC; Princiotta MF; Berglund P; Gibbs J; Bennink JR; Yewdell JW Science; 2004 May; 304(5675):1318-21. PubMed ID: 15166379 [TBL] [Abstract][Full Text] [Related]
31. Genetic characterization of HIV type 1 Nef-induced vesicle secretion. Ali SA; Huang MB; Campbell PE; Roth WW; Campbell T; Khan M; Newman G; Villinger F; Powell MD; Bond VC AIDS Res Hum Retroviruses; 2010 Feb; 26(2):173-92. PubMed ID: 20156100 [TBL] [Abstract][Full Text] [Related]
33. Anchorage to the cytosolic face of the endoplasmic reticulum membrane: a new strategy to stabilize a cytosolic recombinant antigen in plants. Barbante A; Irons S; Hawes C; Frigerio L; Vitale A; Pedrazzini E Plant Biotechnol J; 2008 Aug; 6(6):560-75. PubMed ID: 18444969 [TBL] [Abstract][Full Text] [Related]
34. Expression of human immunodeficiency virus type 1 Gag protein precursor and envelope proteins from a vesicular stomatitis virus recombinant: high-level production of virus-like particles containing HIV envelope. Haglund K; Forman J; Kräusslich HG; Rose JK Virology; 2000 Mar; 268(1):112-21. PubMed ID: 10683333 [TBL] [Abstract][Full Text] [Related]
35. Targeting soluble proteins to exosomes using a ubiquitin tag. Cheng Y; Schorey JS Biotechnol Bioeng; 2016 Jun; 113(6):1315-24. PubMed ID: 26574179 [TBL] [Abstract][Full Text] [Related]
36. MVA-nef induces HIV-1-specific polyfunctional and proliferative T-cell responses revealed by the combination of short- and long-term immune assays. Kutscher S; Allgayer S; Dembek CJ; Bogner JR; Protzer U; Goebel FD; Erfle V; Cosma A Gene Ther; 2010 Nov; 17(11):1372-83. PubMed ID: 20535218 [TBL] [Abstract][Full Text] [Related]
37. Generation of HIV-1 Virus-Like Particles expressing different HIV-1 glycoproteins. Visciano ML; Diomede L; Tagliamonte M; Tornesello ML; Asti V; Bomsel M; Buonaguro FM; Lopalco L; Buonaguro L Vaccine; 2011 Jul; 29(31):4903-12. PubMed ID: 21596074 [TBL] [Abstract][Full Text] [Related]
38. HIV-1 Nef equips dendritic cells to reduce survival and function of CD8+ T cells: a mechanism of immune evasion. Quaranta MG; Mattioli B; Giordani L; Viora M FASEB J; 2004 Sep; 18(12):1459-61. PubMed ID: 15240562 [TBL] [Abstract][Full Text] [Related]
39. mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients. Van Gulck E; Vlieghe E; Vekemans M; Van Tendeloo VF; Van De Velde A; Smits E; Anguille S; Cools N; Goossens H; Mertens L; De Haes W; Wong J; Florence E; Vanham G; Berneman ZN AIDS; 2012 Feb; 26(4):F1-12. PubMed ID: 22156965 [TBL] [Abstract][Full Text] [Related]
40. In vivo induction of cellular and humoral immune responses by hybrid DNA vectors encoding simian/human immunodeficiency virus/hepatitis B surface antigen virus particles in BALB/c and HLA-A2-transgenic mice. Marsac D; Puaux AL; Rivière Y; Michel ML Immunobiology; 2005; 210(5):305-19. PubMed ID: 16164038 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]